...
Richard Norman (Unlicensed) (Pistoia Alliance)
Francisco Fernandez (Deactivated) (Abvance Biotech)
- Bryan Jones (Deactivated) (Eli Lilly)
- Helen Li (Unlicensed) (Eli Lilly)
- Chris Lloyd (Deactivated) (MedImmune)
- Carmen Nitsche (Deactivated) (Pistoia Alliance)
- Kieran Todd (Deactivated) (GSK)
Discussion items
Time | Item | Who | Notes |
---|---|---|---|
17:00 - 18:00 (60 mins) | >Feedback on AbVance II doc: https://drive.google.com/open?id=1pYna8ydvyN4vyZnRV5jxhL9I8xHRdgny >Validating the problem statements. >Defining the scope. >What do we want to achieve by end of June? -define content of EMBL-EBI presentation. -define what we want out of workshop. -workshop attendance. >Next steps, e.g. agenda for next week’s PTM >Sign up for proposal on IP3 | Richard, All | >Further develop thinking around proposal and EMBL-EBI workshop presentation
|
Minutes
Feedback on AbVance II doc
...